{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to assess the usage pattern of Gabapentin extended-release formulation in the management of neuropathic pain in India

Survey Questionnaire Form
Doctor’s details
@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of Neuropathic pain do you see in a month? *

  2. From your clinical experience, mention the most common type of Neuropathic pain patients that present to you at diagnosis? *

  3. Do you consider Gabapentin as a first-line treatment for neuropathy? *

  4. What percentage of your neuropathy patients achieve satisfactory symptom relief with Gabapentin alone? *

  5. What percentage of your neuropathy patients are currently prescribed Gabapentin GRS formulation treatment? *

  6. In your experience, how effective do you find Gabapentin GRS formulation in managing neuropathy symptoms? *
  7. On a scale of 1 to 5, How satisfied are you with the current dosing options available for Gabapentin GRS formulation? (5 being very satisfied) *

  8. In your experience, how quickly do patients typically respond to Gabapentin GRS formulation treatment? *

  9. Which factors are critical for choosing Gabapentin GRS formulation in neuropathic pain? *
  10. How often do you adjust the dosage of Gabapentin GRS formulation for optimal symptom management? *

  11. On average, how long do your patients remain on Gabapentin GRS formulation treatment? *

  12. What is your typical starting dose of this formulation in neuropathy patients? *

  13. Do you prefer prescribing the Gabapentin GRS once daily formulation over other Gabapentin formulation? If no, please specify reason. *

  14. In your experience, does Gabapentin GRS formulation provide long-term benefits for peripheral neuropathy patients? *

  15. Have you observed any differences in treatment response based on patient’s age when prescribing Gabapentin GRS formulation in neuropathy patients? *

  16. Have you observed any differences in treatment response based on patient’s gender when prescribing Gabapentin GRS formulation in neuropathy patients? *

  17. What percentage of your patients report satisfactory compliance with Gabapentin GRS formulation treatment? *

  18. How do you typically monitor the effectiveness of Gabapentin GRS formulation treatment in your patients? *

  19. How satisfied are your patients with the response of the Gabapentin GRS formulation in managing their peripheral neuropathic pain? (5 being very satisfied) *

  20. How satisfied are your patients with the tolerability of the Gabapentin GRS formulation in managing their neuropathic pain? (5 being very satisfied) *

  21. In your experience, what are the different types of neuropathic pain where Gabapentin GRS formulation is more effective and why? *
  22. Do you find Gabapentin GRS formulation more effective than other medications commonly prescribed for neuropathy? *

  23. What percentage of adult patients are exhibiting satisfactory tolerance with Gabapentin GRS formulation? *

  24. What proportion of your neuropathy patients require dose titration with Gabapentin GRS formulation? *

  25. What percentage of your neuropathy patients experience significant improvement in quality of life with Gabapentin GRS formulation? *

  26. How do you adjust gabapentin extended-release dosage in patients with renal impairment ? *
  27. How frequently do you encounter patients who discontinue Gabapentin GRS formulation due to lack of efficacy? *

  28. In your experience, do patients with neuropathic pain having comorbidities influence your decision to prescribe Gabapentin GRS formulation and Why? *
  29. Based on your experience, do you think additional research is needed to better understand Gabapentin GRS formulation in neuropathy management? *

  30. In your opinion, what advantage does Gabapentin GRS formulation offer over other drugs in neuropathy management? *
  31. How would you rate your overall experience with prescribing Gabapentin GRS formulation in neuropathy management? (5 being very satisfied) *

  32. How do you adjust the treatment plan based on the disease progression? *